About Hims & Hers Health, Inc. 
Hims & Hers Health, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 83 Schemes (38.46%)
Foreign Institutions
Held by 153 Foreign Institutions (9.92%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
545 Million
(Quarterly Results - Jun 2025)
Net Profit:
43 Million
Pharmaceuticals & Biotechnology
USD 11,220 Million (Small Cap)
74.00
NA
0.00%
-0.31
36.41%
19.94






